TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03589859

Intervention type: DIAGNOSTIC_TEST
Intervention: VOR Test
Description: Video-oculography is used to record the vestibulo-ocular reflex during active and passive turns of the head.

Intervention type: DIAGNOSTIC_TEST
Intervention: VOR Test
Description: Video-oculography is used to record the vestibulo-ocular reflex during active and passive turns of the head.

Intervention type: OTHER
Intervention: Computer Game
Description: Participants play a custom computer game that is designed to produce motor learning in the vestibulo-ocular reflex

Intervention type: OTHER
Intervention: Computer Game
Description: Participants play a custom computer game that is designed to produce motor learning in the vestibulo-ocular reflex

Intervention type: OTHER
Intervention: Nausea Scale
Description: Participants asked to rate their subjective nausea on a numeric scale after playing units of the computer game
Study: NCT02099864

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Description: Given PO
Study: NCT02157532

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: mechanical thrombectomy
Description: Mechanical thrombectomy using any already approved stent-retriever device

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Best standard treatment
Description: Intravenous r-tPA infusion or any other medical management option
Study: NCT04250857

Intervention type: DEVICE
Intervention: HeartStart FRX
Description: Automated External Defibrillator
Study: NCT03466918

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SAPIEN 3 THV with the Commander delivery system
Description: Edwards SAPIEN 3 Transcatheter Heart Valve is implanted using the Commander delivery system
Study: NCT03590028

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early Nephrology Consult (ENC)
Description: The electronic risk prediction algorithm (ESTOP-AKI) will interface with electronic medical data to determine the likelihood for the patient to develop AKI. Early Nephrology Consult (ENC) will be implemented. A nephrologist will assess the subject and consult with their care team to advise a treatment plan during the hospitalization.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care (SOC)
Description: Subjects will receive nephrology consultation at the typical timepoint after symptoms of AKI appear.
Study: NCT01787500

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan Hydrochloride
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vemurafenib
Description: Given PO
Study: NCT02110719

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: percocet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: vicodin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dilaudid

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dilaudid

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: zofran
Study: NCT00926497

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided decision making
Description: Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early onset sepsis
Study: NCT06599346

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: Participants in this arm will receive standard care for mucosal injuries, which may include oral rinses, topical treatments, and supportive care based on the type of injury.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MSC Supernatant + Standard Care
Description: Participants in this arm will receive MSC supernatant in addition to standard care. MSC supernatant will be administered as follows:~15 mL for oral mucosal injuries (mouthwash) Topical application for skin mucosal injuries (based on body surface area) 50 mL for bladder injuries (bladder irrigation)
Study: NCT03397966

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: recombinant human BNP(1-32)
Description: Subjects will receive an IV infusion of recombinant human BNP(1-32) for 240 minutes at a rate of 10 ng/kg/minute for 240 minutes, preceded by an IV bolus of 100 ng/kg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: recombinant human BNP(1-32)
Description: Subjects will receive an IV infusion of recombinant human BNP(1-32) for 240 minutes at a rate of 10 ng/kg/minute for 240 minutes, preceded by an IV bolus of 100 ng/kg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo (control, normal saline)
Description: Subjects will receive an IV infusion of placebo (normal saline) at a rate of 10 ng/kg/minute for 240 minutes, preceded by an IV bolus of 100 ng/kg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo (control, normal saline)
Description: Subjects will receive an IV infusion of placebo (normal saline) at a rate of 10 ng/kg/minute for 240 minutes, preceded by an IV bolus of 100 ng/kg.
Study: NCT03300128

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incredible Years - ASD
Description: The IY-ASD intervention is designed for parents of children with autism spectrum disorder. The programs uses a mix of videos, collaborative brainstorming sessions, and role plays to deliver content on child-directed play and positive discipline practices.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Circle of Parents
Description: Circle of Parents is an open parent support group led by a parent leader. Participants are encouraged to share resources and other support both during groups, and between meetings.
Study: NCT06284005

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WRL ATP
Description: evaluation of functionality, degree of safety and reliability of the lower limb prosthesis prototype
Study: NCT04351711

Intervention type: OTHER
Intervention: Immunological profiling
Description: The immune activation phenotype will be assessed using a standardized panel of soluble and membrane immune activation markers

Intervention type: OTHER
Intervention: Immunological profiling
Description: The immune activation phenotype will be assessed using a standardized panel of soluble and membrane immune activation markers

Intervention type: OTHER
Intervention: Immunological profiling
Description: The immune activation phenotype will be assessed using a standardized panel of soluble and membrane immune activation markers

Intervention type: OTHER
Intervention: Immunological profiling
Description: The immune activation phenotype will be assessed using a standardized panel of soluble and membrane immune activation markers

Intervention type: OTHER
Intervention: Immunological profiling
Description: The immune activation phenotype will be assessed using a standardized panel of soluble and membrane immune activation markers

Intervention type: OTHER
Intervention: Immunological profiling
Description: The immune activation phenotype will be assessed using a standardized panel of soluble and membrane immune activation markers

Intervention type: OTHER
Intervention: Immunological profiling
Description: The immune activation phenotype will be assessed using a standardized panel of soluble and membrane immune activation markers
Study: NCT04696757

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine without surgery
Study: NCT03215056

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methoxyflurane
Description: PENTHROX 3mL inhalation vapour, liquid

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Placebo
Study: NCT04462640

Intervention type: OTHER
Intervention: Management of Infant Digestive Disorders and Quality of Life
Description: The variation of the QUALIN score on D30 compared to inclusion (D0) will be described and compared using a Student test for paired data in the case of a normal distribution or a test of the ranks signed by Wilcoxon otherwise.

Intervention type: OTHER
Intervention: Management of Infant Digestive Disorders and Quality of Life
Description: The variation of the QUALIN score on D30 compared to inclusion (D0) will be described and compared using a Student test for paired data in the case of a normal distribution or a test of the ranks signed by Wilcoxon otherwise.
Study: NCT04373902

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Physiological-based cord clamping
Description: See 'Arm'
Study: NCT00289653

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicoderm
Study: NCT00270985

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Almonds in a calorie controlled diet
Description: Prescribed daily dose of Almonds in calorie controlled diet for adults with pre-type 2 diabetes

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nut free diet
Description: Calorie controlled diet free of nuts for adults with pre-type 2 diabetes
Study: NCT02582528

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive remediation treatment
Description: Cognitive remediation treatment consisting of a novel computerized training called My Brain Solutions (MBS)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive remediation treatment
Description: Cognitive remediation treatment consisting of a novel computerized training called My Brain Solutions (MBS)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: A client-centered, directive method for enhancing intrinsic motivation to change.
Study: NCT01441999

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Less rigid rod
Description: Titanium rod with semi rigid end

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Rigid Rod
Description: Rigid Titanium rods
Study: NCT01782898

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esmolol administered at a rate of 0.5 mg/kg followed by an infusion of 5-15 mcg/kg/min
Description: Esmolol administered at a rate of 0.5 mg/kg followed by an infusion of 5-15 mcg/kg/min

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator: .9 normal saline
Description: Placebo Comparator: Placebo .9 normal saline infused at the same rate (/mg/kg bolus followed by 5-15 mcg/kg/mn) as the Esmolol would be administered,
Study: NCT04017052

Intervention type: DRUG
Group type: OTHER
Intervention: FSME-IMMUN Vaccine
Description: Booster with TBE vaccine (i.m.) FSME Immun
Study: NCT04879030

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Beta-Lactams
Description: The patient was randomized to use beta-lactams antibiotic

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Beta-Lactams
Description: The patient was randomized to use beta-lactams antibiotic

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluoroquinolone
Description: The patient was indicated to use a combination of beta-lactams and fluoroquinolones
Study: NCT03502928

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Motor Control
Description: Neck Motor Control

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor Control
Description: Neck Motor Control

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual Therapy
Description: Massage + Joint Mobilizations

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual Therapy
Description: Massage + Joint Mobilizations

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry Needling
Description: Dry Needling in Neck Muscles
Study: NCT00878501

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1386
Description: oral, during 4 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1386
Description: oral, during 4 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral, during 4 weeks
Study: NCT03607422

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for Upadacitinib
Description: Tablets taken orally once a day

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Upadacitinib
Description: Tablets taken orally once a day
Study: NCT00960622

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Truvada
Description: Truvada (tenofovir 300mg / emtricitabine 200mg) capsule once daily for 6 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Combivir
Description: Continue on Combivir (150 mg of lamivudine, 300 mg of zidovudine) two tablets daily for 6 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trizivir
Description: Continue on Trizivir (300 mg of abacavir as abacavir sulfate, 150 mg of lamivudine, and 300 mg of zidovudine)
Study: NCT01650532

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga Condition
Description: Classes lasting one hour, held 3 times per week for 8 weeks.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stretching Condition
Description: Classes lasting one hour, held 3 times per week for 8 weeks.
Study: NCT01419236

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone Solution 2%
Description: Administered topically

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Solution
Description: Administered topically
Study: NCT04504734

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bucillamine
Description: 100mg tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 100mg tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bucillamine
Description: 200mg tablets
Study: NCT04054557

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine
Description: Participate in virtual visits with oncologist

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive 4 in-office visits with oncologist

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Practice
Description: Receive 4 in-office visits with oncologist

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Complete electronic survey

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention
Description: Use smart pill bottle

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Intervention
Description: Receives time-specific reminders and messages
Study: NCT01372709

Intervention type: DEVICE
Intervention: Ovation™ or Ovation Prime™ Abdominal Stent Graft System
Description: Single occurrence permanent implant of AAA device.
Study: NCT04419025

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: N-acetylcysteine
Description: Oral formulation: 600 mg capsules of N-acetylcysteine
Study: NCT02506543

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COMPASS
Description: COMPASS (Creating Opportunities through Mentoring, Parental involvement and Safe Spaces) is a program for 13-19 year old girls in three refugee camps in Ethiopia. The program is a structured intervention that is intended to engage adolescent girls, through life skills training and establishing or supporting community-supported safe spaces for girls where they can come and gather among themselves and participate in a structured life-skills curriculum.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No intervention
Description: Wait list control group will not receive an intervention. After the follow-up study, the wait-list control group will receive the regular COMPASS program
Study: NCT02535481

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Epidermal grafting
Description: The Cellutome Epidermal Graft Harvesting System will be used to harvest epidermal grafts.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Split thickness skin grafting
Description: Split thickness skin grafting will be performed as per normal clinical practice.
Study: NCT02541097

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Language therapy
Description: Participants will receive semantic and phonological therapy for words they cannot retrieve spontaneously. They will be given an opportunity to practice the words in a group setting.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Language therapy
Description: Participants will receive semantic and phonological therapy for words they cannot retrieve spontaneously. They will be given an opportunity to practice the words in a group setting.
Study: NCT03659396

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: individualized Tai Chi
Description: individualized Tai Chi training exercise

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Entire Tai Chi
Description: the classical Yang style Tai Chi program

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: home-based program
Description: Home-based exercise
Study: NCT04346745

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer Mentoring Program
Description: The Peer Mentoring Program (PMP) is a 3-month intervention to provide one-on-one mentoring support via phone calls to reduce the stress of Chinese dementia caregivers. The PMP will address the following topics: cultural beliefs about dementia and family caregiving, culturally effective coping strategies, and culturally appropriate social support.
Study: NCT01838694

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ala-Cpn10

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT01630369

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: insulin human (HR1799)
Description: Pharmaceutical form: solution for injection Route of administration: subcutaneous
Study: NCT04540185

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: oral polio vaccine
Description: Bivalent OPV (GSK), 0.1 ml administered orally on a sugar lump

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Comparable Placebo
Description: Placebo of a vaccine 0.1 ml administered orally on a sugar lump

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NA-831
Description: Drug: NA-831 30 mg of NA-831 in a capsule administered orally

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Comparable Placebo of drug
Description: Placebo 30 mg in a capsule administered orally

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Combination of oral polio vaccine and NA-831
Description: Combination of biological: Bivalent OPV (GSK), 0.1 ml administered orally on a sugar lump and drug NA-831 30 mg in a capsule administered orally

Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Comparable Placebo of Oral Polio Vaccine and Placebo of drug
Description: Combination of biological placebo 0.1 ml administered orally on a sugar lump and drug placebo 30 mg in a capsule administered orally
Study: NCT01283841

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mycophenolate Mofetil
Description: Mycophenolate Mofetil 500 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate Mofetil
Description: Mycophenolate Mofetil 500 mg tablets
Study: NCT02039115

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisone
Description: 6 weeks of prednisone and placebo therapy will be given over 6 weeks after both the first and second stage complete Barretts Excision.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 6 weeks of placebo therapy will be given in the same manner as the prednisone arm after the first and second stage complete Barretts excision.
Study: NCT01194830

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Linagliptin
Description: Active drug 1 tablet PO QD

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 Tablet PO QD
Study: NCT05357625

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feedback Informed Treatment
Description: FIT is based on two simple questionnaires and aims to assess and improve the effectiveness of therapeutic treatment. Treatment outcomes are assessed with the Outcome Rating Scale (ORS), a four-item self-report instrument measuring client functioning in the area of quality of life. Therapeutic alliance is assessed using the four-item Session Rating Scale (SRS). In FIT the feedback from the client is used to continuous adjustment and improvement of therapy
Study: NCT03793751

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dexmedetomidine Injection
Description: Dexmedetomidine Injection at a dose of 1 mcg/kg over 10 min, after Spinal Anaesthesia and before start of surgery, followed by a continuous infusion at a rate of 0.4 mcg/kg/h until the end of surgery.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine Injection
Description: Dexmedetomidine Injection at a dose of 1 mcg/kg over 10 min, after Spinal Anaesthesia and before start of surgery, followed by a continuous infusion at a rate of 0.4 mcg/kg/h until the end of surgery.
Study: NCT04364386

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: InPress Device
Description: Treatment with InPress Device for Postpartum Hemorrhage
Study: NCT03607422

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Upadacitinib
Description: Tablets taken orally once a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Upadacitinib
Description: Tablets taken orally once a day
Study: NCT03975491

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Aerobic Exercise
Description: The exercise intervention will consist of moderate-intensity (50-70% age-predicted maximum heart rate) treadmill walking. All exercise sessions will begin with a five-minute warm up of slow walking, 30-60 minutes of moderate-intensity walking, and a five-minute cool down of slow walking.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Wait-List Control
Description: Participants randomized into the wait-list control group are asked to maintain their pre-study levels of physical activity and follow the recommendations provided by their physician.